From Monday 25 May on Ministry of Health and Istat, with the collaboration of Italian Red Cross, started the inational seroprevalence survey of SARS-CoV-2 infection to understand how many people in our country have developed antibodies to the new coronavirus, even in the absence of symptoms.
A survey that will be carried out on a sample of 150 thousand people residents in 2 thousand Municipalities, distributed by gender, activity and six age groups. The results of the survey, disseminated anonymously and in aggregate form, can also be used for other scientific studies and for comparative analysis with other European countries.
The national investigation in the province of Varese it involves 32 municipalities. They are Barasso, Besnate, Busto Arsizio, Cantello, Caronno Pertusella, Casale Litta, Cassano Magnago, Castellanza, Castelseprio, Cittiglio, Fagnano Olona, Gallarate, Gavirate, Gerenzano, Gornate Olona, Induno Olona, Ispra, Luino, Malnate, Marnate, Mornago, Oggiona with Santo, Stefano Origgio, Saltrio, Samarate, Saronno, Somma Lombardo, Tradate, Uboldo, Varese, Venegono Inferiore and Venegono Superiore.
Among the laboratories that will process the tests there is also the Circolo di Varese hospital.
Within the municipalities the selected people will be contacted on the phone by the regional centers of the Italian Red Cross to fix, in one of the selected laboratories, an appointment for blood sampling. The withdrawal can also be performed at home if the subject is fragile or vulnerable. Upon contact, you will also be asked to respond to a specific questionnaire prepared by Istat, in agreement with the Technical Scientific Committee.
The Region will communicate the outcome of the examination to each participant residing in the territory. In case of a positive diagnosis, the interested party will be placed in temporary home isolation and contacted by their regional health service or ASL to make a nose-pharyngeal swab that checks for any state of contagiousness. The confidentiality of the participants will be maintained for the duration of the investigation.
All participants will be assigned an anonymous identification number for the acquisition of the test result. The link of this identification number with individuals will be managed by the investigation team and will be disclosed only to authorized bodies.